Table 2

Framework for quality assessment of HEE quality appraisal instruments
Dimension Item
A. Purpose and scope A1. The reasons for developing the guideline are stated
A2. The overall objective of the guideline is described
A3. The health economic studies for which the guideline was designed are stated
A4. The target audience of the guideline is characterized
A5. The time frame to which the guideline is meant to apply is specified
B. Stakeholder involvement B1. The guideline development group consists of individuals from all relevant disciplines
B2. Conflicts of interest of guideline development group members have been recorded and addressed
B3. The views and preferences of the target audience have been sought
C. Rigor of development process/validity C1. The members of the guideline development group and their affiliations are stated
C2. The methods used for literature search are specified
C3. The sources of evidence on which the guideline is based are described
C4. The criteria for selecting existing evidence are described
C5. The methods for formulating the items are specified
C6. The methods used to reach consensus are specified
C7. The date for reviewing/updating the guideline is stated
C8. The guideline is valid in terms of:
C8a. Content (internal) validity
C8b. Criterion (external) validity
C8c. Construct validity (convergent and discriminant validity)
D. Reliability/ reproducibility D1. The process of guideline development is documented
D2. The guideline has been externally reviewed by experts prior to its publication
D3. The guideline has been piloted/pretested among the target audience
D4. The guideline is reliable in terms of:
D4a. Inter-rater reliability
D4b. Test-retest reliability
D4c. Parallel-forms reliability
D4d. Internal consistency reliability
E. Clarity of presentation E1. The items of the guideline are specific and clearly worded
E2. The items of the guideline are clearly presented and user friendly
E3. The guideline can be used in a straightforward manner
E4. Key items are easily identifiable
F. Applicability F1. The guideline provides a standard reporting format
F2. The guideline gives a detailed assessment instruction
F3. The guideline presents items of methodological quality and transparency
F4. The guideline uses a quality score
F5. The strengths and limitations of the guideline are specified
G. Evaluation G1. The methods for evaluating the guideline are described
G2. The adherence to the guideline by the target audience is described

Langer

Langer BMC Health Services Research 2012 12:253   doi:10.1186/1472-6963-12-253

Open Data